Showing results (51-60 of 61) with videos related to
Sort By:
Pageof 7
Biorxiv : the Preprint Server for Biology|April 15, 2024
Detection of clade 2.3.4.4b highly pathogenic H5N1 influenza virus in New York CityPhilip S Meade, Pooja Bandawane, Kaitlyn Bushfield, et al.Cancer Cell|May 30, 2006
The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapiesHongbin Ji, Danan Li, Liang Chen, et al.Cancer Research|September 6, 2022
MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung CancerRyohei Yoshida, Maria Saigi, Tetsuo Tani, et al.Cell|March 5, 2021
An expanded universe of cancer targetsWilliam C Hahn, Joel S Bader, Theodore P Braun, et al.Journal of the American Society for Mass Spectrometry|October 21, 2017
Proof of Concept Coded Aperture Miniature Mass Spectrometer Using a Cycloidal Sector Mass Analyzer, a Carbon Nanotube (CNT) Field Emission Electron Ionization Source, and an Array DetectorJason J Amsden, Philip J Herr, David M W Landry, et al.British Journal of Sports Medicine|August 28, 2024
Effects of reducing sedentary behaviour by increasing physical activity, on cognitive function, brain function and structure across the lifespan: a systematic review and meta-analysisNatan Feter, Tomasz S Ligeza, Neha Bashir, et al.The Journal of Clinical Investigation|February 17, 2026
Pathobiont-triggered induction of goblet cell response drives regional susceptibility to Inflammatory Bowel DiseasePaige N Spencer, Monica E Brown, Erin P Smith, et al.Biorxiv : the Preprint Server for Biology|January 13, 2025
Pathobiont-triggered induction of epithelial IDO1 drives regional susceptibility to Inflammatory Bowel DiseasePaige N Spencer, Jiawei Wang, Erin P Smith, et al.Cell|December 8, 2023
Molecular cartography uncovers evolutionary and microenvironmental dynamics in sporadic colorectal tumorsCody N Heiser, Alan J Simmons, Frank Revetta, et al.Bladder Cancer (Amsterdam, Netherlands)|July 5, 2016
Summary and Recommendations from the National Cancer Institute's Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder CancerSeth P Lerner, Dean F Bajorin, Colin P Dinney, et al.Pageof 7